COMPOSITIONS OF ADAGRASIB AND mTOR INHIBITORS AND METHODS OF TREATMENT THEREWITH
US20260097038A1 · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name MIRATI THERAPEUTICS, INC..
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
US20260097038A1 · Application publication visible